IL17A and cancer: Pro-tumor neutrophils may also contribute to the immune escape by cancer cells through the expression of immune checkpoint proteins (i.e., PD-L1), overexpression of other immunosuppressive molecules, such as IDO and NOS, or secretion of the molecules involved in Treg recruitment (i.e., IL-17) [10,128].